-
Alembic Pharmaceuticals gets USFDA nod for generic migraine treatment injection
10 Nov 2025 10:19 GMT
… its generic version of Sumatriptan injection used in treatment of migraine.
The … for the Abbreviated New Drug Application (ANDA) Sumatriptan Injection of strengths 4 … single-dose autoinjector system, Alembic Pharmaceuticals said in a regulatory filing …
-
Alembic Pharma receives US FDA final approval for sumatriptan injection USP, 4 mg/0.5 mL and 6 mg/0.5 mL, single-dose autoinjector system
10 Nov 2025 07:23 GMT
… amp; Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) sumatriptan injection … treatment of cluster headache.
This is Alembic’s first drug … tentative approvals) from US FDA.
Alembic Pharmaceuticals Limited, a vertically integrated …
-
9 Foods That Are Nature’s Medicine for Headaches
09 Nov 2025 09:48 GMT
… as effective as the medication sumatriptan in treating acute … masked, placebo-controlled 2020 trial, stating, "Studies suggest that … can significantly improve migraine treatments.
"Water-rich … a five-year period, doctors at a neurology clinic …
-
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Sumatriptan Injection USP, 4 mg/0.5 mL and 6 mg/0.5 mL, Single-Dose Autoinjector System
08 Nov 2025 09:07 GMT
… ) for its Abbreviated New Drug Application (ANDA) Sumatriptan Injection USP, 4 mg … .
Sumatriptan injection is indicated in adults for (1) the acute treatment of … ) from USFDA.
Shares of Alembic Pharmaceuticals Limited was last trading in …
-
A Pharmacovigilance Study from 2004 to 2024 Utilizing the FDA Adverse Event Reporting System (FAERS) Examines Ischemic Adverse Events Linked to Triptan Use in Migraine Therapy
11 Oct 2025 10:37 GMT
… pre-marketing clinical trials due to limited … rizatriptan, sumatriptan, and zolmitriptan) used in migraine treatment. The FDA-managed … number, submission date, medication (triptan drug), indication (such as … in observational research. Pharmaceut Med. 2022;36 …
-
FDA use of Real-World Evidence in Regulatory Decision Making
23 Sep 2025 03:56 GMT
… severe hypocalcemia). FDA Drug Safety Communication: FDA adds Boxed … Pharmaceuticals, Inc
Medicare claims data
Retrospective cohort study
In FDA … trial used to approve Pradaxa. FDA … patients
Imitrex (sumatriptan), Treximet® (sumatriptan and naproxen sodium) …
-
NYITCOM faculty receives grant to study new migraine treatment
11 Sep 2025 03:05 GMT
… aims to uncover new migraine treatments for patients who do not … targets something that currently available medicines like Sumatriptan or triptan don’t … explore a new kind of treatment that targets α9α10 … safe as well as effective drug that are effective for a …
-
Bright Minds Biosciences Announces BMB‑201 Outperforms Sumatriptan in Validated Preclinical Vascular Headache Model
04 Sep 2025 12:30 GMT
… greater effect sizes than sumatriptan at multiple timepoints. … is a biotechnology company developing innovative treatments for patients … conditions with high unmet medical need, including epilepsy, … to operating in the pharmaceutical industry, and inaccuracies …
-
What Medicine Can You Take While Pregnant? Plus, Which Drugs To Avoid
23 Aug 2025 09:12 GMT
… doctor before taking sumatriptan during pregnancy. Avoid combination sumatriptan … magnesium (first-line treatment in pregnancy).
Sucralfates …
Nonsteroidal anti-inflammatory drugs (NSAIDs) like … your doctor before taking any medication.
Natural Remedies
…
-
Migraine Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals, MOA, ROA, NDA, IND, And Companies
22 Aug 2025 01:57 GMT
… a study medicine called … treatment.
The leading Migraine Companies such as Satsuma Pharmaceuticals, Biohaven Pharmaceuticals … Clinical Trials Assessment
Migraine Emerging Drugs Profile
… (Eptinezumab), Ketorolac, Sumatriptan, divalproex sodium, Erenumab …
About
© 1995-2025